Virologist Beata Halassy, ​​facing a recurrent tumor, develops and tests on herself an innovative therapy: here is her story.

Virologist treats breast cancer with oncolytic virotherapy, shrinking the tumor and boosting immune response. An ...

Oncolytic viruses – viruses that selectively target and ... “I was extremely touched by the experience, and it reinforced the ...

Candel Therapeutics aims to revolutionize cancer treatment with oncolytic virus therapy, awaiting crucial trial results in Q4 ...

"Oncolytics targets accelerated approval for oncolytic virus therapy" was originally created and published by Pharmaceutical ...

Researchers from Queen Mary University of London, the Chinese Academy of Sciences and Capital Medical University in Beijing ...

(GLOBE NEWSWIRE) -- (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on ...

MB-108 shows activity and is well tolerated in recurrent glioblastoma, with preclinical data supporting its combination with ...

Clinical-stage immuno-oncology company Imugene is celebrating more than two years’ “complete response” for one of its bile ...

Our improved understanding of NDV biology, tropism, mechanisms of oncolysis and oncolytic specificity for cancer cells and the development of the reverse genetics system have paved the way for the ...

Imugene stocks well placed to grow with clinical progress on azer-cel CAR T-cell therapy and strong cash position, say analysts ...